Amgen (AMGN) and Kyowa Kirin (KYKOF) announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an ...
Prenatal exposure to fine particulate matter (PM2.5) at levels above 65 µg/m³ was associated with a sharp rise in atopic ...
Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics ...
Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...
Lawrence Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the importance of shared decision-making in atopic dermatitis treatment, emphasizing ...
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream ...
Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology Studies
Insights into Hidradenitis Suppurativa from Target RWE Featured in Posters at AAD 2025 DURHAM, N.C., March 7, 2025 ...
Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback